Summary Transgenic mice expressing the c-myc proto-oncogene under the control of the CD2-dominant control region show stochastic development of mainly clonal thymic lymphoma with long latency, indicating that cooperative events are needed for the development of the fully malignant phenotype. Previous studies have suggested that T-cell receptor-associated signals can contribute to tumour development. We have therefore used this transgenic model of T-cell transformation to determine whether antigen-specific responses could constitute an epigenetic event in lymphomagenesis. The T-cell receptor (TcR) repertoires of lymphoma clones were analysed with a panel of monoclonal antibodies (Abs) recognizing TcR VD chains. The V,B repertoire of tumour clones arising in these mice was non-random with overrepresentation of VP8.2 TcR species. The majority of Vf8.2+ clones were of a mature CD3+ CD8 single-positive (SP) phenotype. The biased TcR usage, together with a mature cell phenotype is consistent with the hypothesis that TcR-mediated signals cooperate with activated myc during T-cell transformation.
A series of events, both genetic and epigenetic, are required to transform healthy cells to the fully malignant tumour phenotype. While many heritable genetic changes resulting in activation of cellular proto-oncogenes and/or inactivation of tumour-suppressor genes have been identified, the nature and spectrum of epigenetic events that can contribute to the transformation process is less well defined.
In malignancies of mature lymphoid cells it has been suspected that epigenetic events such as stimulation via conventional T-and B-cell antigen receptors may contribute to tumorigenesis. Some of the most convincing data have arisen from studies on human follicular lymphoma. Bahler and Levy (1992) reported that mutations of the immunoglobin heavy-chain variable region continued after follicular lymphoma development, indicating an important role for antigen in the clonal evolution of the lymphoma. Further, the non-random nature of mutations within the variable gene sequences of follicular lymphomas and the finding that surface immunoglobin expression is often preserved led Zelenetz et al (1992) to suggest that these lymphomas were subject to both positive and negative selection. The possibility that self antigens are playing a role in the selection process is supported by the finding that autoantibody production by follicular lymphomas is a relatively frequent occurrence (Dighiero et al, 1991) .
The association between H. lylori infection and gastric B-cell lymphoma and the finding that antibiotic treatment can result in the regression of low-grade lymphomas (Wotherspoon et al, 1993) have resulted in the suggestion that antigen stimulation may play a role in the development of these lesions. Studies carried out by Hussell et al (1993) have indicated a role for T-cells in this chronic, possibly autoreactive, response. Similarly, the development of polyclonal plasmacytomas localized to the gut wall in E,umyclv-abl double transgenic mice has led to the suggestion that tumour initiation involves stimulation by gut-associated antigen Rosenbaum et al, 1990) . In agreement with this hypothesis, antigenic stimulation has also been reported to contribute to the plasmacytomagenesis induced by a myc/v-abl retrovirus (Weissinger et al, 1991) .
The possibility that signals mediated through the T-cell receptor (TcR) could contribute to the transformation of lymphoid cells arose from our studies on the pathogenesis of FeLV-induced thymic lymphomas. During analysis of proviral integrations in tumours, we observed one tumour with two separate retroviral transductions. One transducing virus contained the myc oncogene, while the other contained a processed and structurally intact TcR 5-chain (Fulton et al, 1987) . This observation suggested that oncogenic complementation between myc and the transduced TcR Pchain may have favoured clonal outgrowth, leading us to develop a murine model, the CD2-myc mice, to further investigate the involvement of the TcR in myc-induced lymphomagenesis (Cameron et al, 1996) . The CD2-myc transgenic mice develop thymic tumours exclusively. The long latency, the moderate incidence and the clonal nature of these tumours implies that in addition to myc deregulation, additional events are required for tumour development. Phenotypic examination of these tumours showed that they had either immature CD3+CD4+CD8+ or mature CD3+CD8 SP phenotypes. This limited phenotypic heterogeneity suggests that thymocytes are most susceptible to myc transformation at the *Present address: Wellcome Institute, Department of Biochemistry, University of Dundee, Dundee DD1 4HN, UK developmental stage(s) when selection events are expected. We have previously reported that a small number of these tumours comprised T-cells that expressed a potentially autoreactive TcR VP chain (Cameron et al, 1996) and that such tumours were significantly associated with the mature CD3+CD8 SP phenotype. These results suggested that negative selection or clonal anergy may be bypassed and that endogenous antigen may generate additional proliferative signals.
To further define the nature and extent of TcR involvement in tumour induction/progression, we have placed the CD2-myc transgene on a genetic background in which a large number of TcR V,B families are subjected to negative selection and examined the tumour T-cell repertoire. Surprisingly, there was an apparent bias in usage of non-deleted TcR V,8.2 in tumours that were also predominantly of a mature phenotype. Considered together, these data describe tumours comprising cells with characteristics of a mature and antigen-restricted phenotype, suggesting the TcR may mediate a signal(s) that can interact with myc in T-cell transformation.
MATERIALS AND METHODS

Transgenic mice
The generation of the CD2-myc transgenic mice has been described (Stewart et al, 1993) . The myc transgenic mice (C57BL/6J and CBA/Ca mixture, hereafter referred to as B6/CBA) were backcrossed to DBA/2 mice. The resultant F, progeny were sacrificed when presenting with clinical signs of tumour development, and the thymic lymphomas were removed and frozen in liquid nitrogen as a single-cell suspension for flow cytometric analysis. Other tissues were also snap frozen for comparative analysis.
Southern blot DNA analysis
Analysis of immunoglobin or T-cell receptor gene rearrangements were used to determine thymic lymphoma clonal complexity. Highmolecular-weight DNA was prepared from thymic lymphocytes and intact kidney using the Nucleon II kit (Scotlab). Restriction enzyme digestion, agarose gel electrophoresis and DNA hybridization was performed as previously described (Neil et al, 1984) . Digested DNA was transferred to Hybond N membranes (Amersham Intemational) according to the manufacturer's protocol. Immunoglobulin gene rearrangements were detected using a 1.7-kb BamHV/EcoRI fragment J1 1 from the Ig heavy-chain locus J cluster (Marcu et al, 1980) . TcR gene rearrangements were detected using a 496-bp polymerase chain reaction (PCR)-generated fragment of the Co region derived from a 1.2-kb fragment of clone 86T5 (Hendrick et al, 1984) or a 750-bp EcoRI/HindIII fragment of JP2 from the TcR c J locus (Palacios and Samaridis, 1991) . Probes were radiolabelled by random priming using [a-32P] were obtained from tissue culture supematants (hybridomas kindly provided by Dr P Marrack, Howard Hughes Medical Institute, Co, USA) and purified by protein A-Sepharose affinity chromatography. Biotinylation was performed using biotin-N-hydroxysuccinimide according to manufacturers recommendations (Amersham Intemational). Biotinylated Ab recognizing TcR V11, VP14 and V,8.1,.2 were purchased from Pharminigen. All biotinylated Abs were visualized with streptavidin-RED613 secondary reagent (Gibco BRL). Phenotypic characterization was performed using anti-CD4-PE, anti-CD8-FITC (Serotec, UK), anti-CD3e-Quantum Red (Sigma), anti-CD69-FITC (Pharminigen) and anti-HSA-PE (Pharminigen). Total a/pTcR expression was determined using an Ab that reacts with all oc[,TcR (Kubo et al, 1989) 
RESULTS
Biased usage of the V138.2 T-cell antigen receptor in CD2 thymic lymphoma
The TcR repertoire in mice is strongly influenced by the products of endogenous mouse mammary tumour proviruses (MMTV; Mtv loci). Thymocytes expressing TcR VP elements that are reactive with MMTV-associated superantigens (SAg) undergo negative selection, resulting in deletion of the vast majority of cells; this is reflected by the almost complete absence of these cells from the peripheral T-cell population (Simpson et al, 1994) . As (B6/CBA x DBA/2)F1 mice carry numerous Mtv (Coligan et al, 1994) , it was expected that a large number of TcR VP families would be deleted (e.g. VP3, 5, 6, 7, 8.1, 9, 11) , while VP8.2, VP8.3 and VP14 would be among those spared (Coligan et al, 1994) .
The VP repertoire of myc-induced T-cell lymphomas was investigated by screening a cohort of 20 tumours arising in CD2-myc transgenic mice on a B6/CBA x DBA/2 (F1) background. We have previously reported that myc-induced thymic tumours can comprise cells displaying a 'forbidden' VP phenotype (Cameron British Journal of Cancer (1997) 76(6) (Figure 1 and results not shown). We have found that non-productive IgH rearrangements, which are relatively frequent (30-50%) in normal T-cell development (Born et al, 1988) , are useful markers of clonal identity in T-cell tumours (Blyth et al, 1995) . As shown in Figure 1, In addition to mature T-cell populations, CD8 SP cells are also represented in the thymus as a transitional pre-double-positive (DP) population. Such cells do not express detectable CD3 or TcRcx chain, and CD8 antigen expression is defined as low compared with antigen density on mature T-cells (Lucas et al, 1993; Anderson and Perlmutter, 1995) . As six of the nine V,8.2+
clones show high levels of CD3 and CD8 expression levels together with intermediate levels of TcR, they appear to be representative of a post-selection population rather than the pre-doublepositive population of CD3-CD8'o cells. TcR V,B8.2+ clones in tumours 46 and 34, and one of the two clones in tumour 42, expressed low levels of a/, TcR, which was in agreement with the predominant CD3Io DP immature phenotype.
While phenotypic analysis of tumours for CD3, CD4 and CD8 was indicative of a mature, post-selection T-cell phenotype, we sought to define further the developmental compartment of these cells using the conventional activation and maturation markers CD69 and HSA (heat stable antigen) respectively. CD69 is an activation marker that is rapidly induced on mature peripheral T-cells after stimulation through the TcR (Yamashita et al, 1993 ). CD69 has also been shown to be developmentally regulated in its expression on thymocytes. In particular, it is believed that CD69 identifies a subpopulation of thymocytes that are, or have recently been, stimulated through their T-cell receptor complexes during positive and negative selection (Yamashita et al, 1993) . HSA characterizes immature thymocytes from DN to early SP (Lucas et al, 1993 (Lucas et al, , 1994 . As shown in Figure 3, Weissman, 1979; McGrath et al, 1987) and to date there is accumulating evidence that supports this hypothesis (Fulton et al, 1987 , Dighiero et al, 1991 Weissinger et al, 1991; Bahler and Levy, 1992; Cameron et al, 1996 Skewed V,B TcR expression in CD2-myc thymic lymphoma 745 expressed VP8. 1, a potentially autoreactive TcR VP phenotype (data not shown). It is worth noting that the tumours using 'forbidden' VP species are also significantly associated with the CD8 SP phenotype (Cameron et al, 1996) .
The intensity of CD3 and CD8 expression and the presence of the maturation marker HSA on the majority of tumour thymocytes strongly suggests that the VP8.2+ clones are derived from thymocytes that were undergoing or that have undergone selection. The restricted phenotype of these tumours and the involvement of both positively and negatively selected TcR VP are in keeping with our previous hypothesis that myc transformation is tightly associated with the window of thymic development during which repertoire selection occurs (Cameron et al, 1996) .
These results suggest that selection events, mediated through the TcR, may collaborate with myc during leukaemogenesis. The exact nature of such interactions is less clear. It is possible that initial transforming events occur at the DP stage and that, in a proportion of tumours, TcR-specific interactions act both as a contributing tumorigenic event and as a maturation signal. If events analogous to positive selection are crucial for the survival of preneoplastic lymphocytes, it might be expected that all T-cells that are positively selected would be equally susceptible to transformation. The skewed repertoire we have reported here indicates that this is not the case, raising the possibility that the signals that complement transformation in the VP8.2-expressing tumour clones are qualitatively or quantitatively different.
One possibility is that interactions with superantigens and normal MHC/peptide complexes may result in different outcomes. Endogenous Mtv proviral sequences play an important role in shaping the T-cell repertoire of mice via superantigen-mediated negative selection of specific VP families. Until recently, there were no reports of Mtv expression resulting in VP-specific positive selection. However, Scherer et al ( 1995) have shown that there is a significant over-representation of Vf8.2+ CD4+ cells in mice carrying Mtv 11, suggesting that this Mtv loci could positively select VP8.2+ thymocytes. Mtv 8 also led to an increase in VP8.2+
T-cells, although this increase was not significant. As the mice used in our study were an F, offspring from DBA2 and C57B 16 x CBA\Ca mice, they harboured both Mtv 11 and Mtv 8.
Skewing of the tumour repertoire need not necessarily involve endogenous or exogenous superantigen as it is clear that specific micro-organisms and antigens preferentially use certain a/ TcR combinations (for reviews see Nanda and Sercarz, 1993; Pannetier et al, 1995) Furthermore, in mice that lack endogenous Mtv sequences, CD4 and CD8 lymph node T-cells show marked differences in VP usage (Scherer et al, 1995) . It is conceivable that emerging tumour clones expressing VP8.2 are supported by a widely expressed and/or abundant conventional antigen in the thymus. In support of this notion, a number of recent studies suggest that antigen-driven proliferation of early SP cells does occur to some extent in normal thymus medulla (reviewed by Scollay and Godfrey, 1995) .
Differences between the VP repertoire of normally selected thymocytes and tumours emerging from this population strongly suggest that TcR-mediated signals complement myc activation in the development of thymic lymphoma. From these studies, it is not possible to determine whether the TcR is important for establishment of the tumour alone or whether it is required for sustained clonal outgrowth. Further studies will focus on the functional importance of the TcR on tumour growth and the nature of the antigen(s) involved.
